HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinyang Li Selected Research

polypeptide C

1/2021A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated.
10/2020ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy.
1/2019Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinyang Li Research Topics

Disease

29Neoplasms (Cancer)
01/2022 - 07/2016
10Adenocarcinoma
10/2021 - 01/2018
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2019
6Neoplasm Metastasis (Metastasis)
01/2022 - 01/2020
5Glioma (Gliomas)
01/2021 - 01/2019
4Dry Eye Syndromes (Dry Eye Syndrome)
11/2015 - 01/2012
3Infections
01/2020 - 01/2018
2Hypoxia (Hypoxemia)
12/2021 - 01/2019
2Liver Neoplasms (Liver Cancer)
12/2021 - 12/2021
2Mycoses (Diseases, Fungus)
01/2021 - 01/2020
2Wounds and Injuries (Trauma)
11/2020 - 01/2018
2Melanoma (Melanoma, Malignant)
01/2020 - 01/2018
2Inflammation (Inflammations)
01/2018 - 01/2012
1Heart Failure
01/2022
1Hepatocellular Carcinoma (Hepatoma)
12/2021
1Esophageal Neoplasms (Esophageal Cancer)
10/2021
1Reinfection
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Hypothermia
01/2021
1Keratitis
01/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Disease Progression
01/2021
1Thrombosis (Thrombus)
12/2020
1Schizophrenia (Dementia Praecox)
11/2020
1Paranoid Personality Disorder
11/2020
1Glioblastoma (Glioblastoma Multiforme)
10/2020
1Arteritis
01/2020
1Bronchiolitis Obliterans Syndrome
01/2020
1Retinoblastoma (Glioblastoma, Retinal)
01/2020

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2018
4Pharmaceutical PreparationsIBA
10/2020 - 01/2019
3Biological ProductsIBA
01/2022 - 01/2018
3LigandsIBA
01/2021 - 01/2019
3polypeptide CIBA
01/2021 - 01/2019
3Immune Checkpoint InhibitorsIBA
10/2020 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2011
2Oxygen (Dioxygen)IBA
01/2022 - 01/2021
2HydrogelsIBA
12/2021 - 09/2015
2AntibodiesIBA
01/2021 - 10/2020
2IntegrinsIBA
01/2021 - 10/2020
2Liposomes (Liposome)IBA
01/2021 - 10/2020
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020 - 01/2020
2Estrogen ReceptorsIBA
01/2020 - 01/2018
2GemcitabineFDA Link
01/2020 - 01/2019
2Peptides (Polypeptides)IBA
01/2020 - 11/2019
2GTP-Binding Proteins (G-Protein)IBA
01/2020 - 01/2018
2Ophthalmic Solutions (Eye Drops)IBA
09/2015 - 01/2012
2Interleukin-6 (Interleukin 6)IBA
09/2013 - 01/2012
2Interleukin-17 (Interleukin 17)IBA
09/2013 - 01/2012
1SodiumIBA
01/2022
1Neprilysin (Neutral Endopeptidase)IBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2022
1AgarIBA
12/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021
1Cisplatin (Platino)FDA LinkGeneric
12/2021
1Caspase 3 (Caspase-3)IBA
12/2021
1regorafenibIBA
12/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021
1SurvivinIBA
01/2021
1ArtemetherFDA Link
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1AntigensIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2021
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021
1Angiogenesis InhibitorsIBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1Parathyroid Hormone-Related ProteinIBA
01/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021
1Inhibitor of Apoptosis ProteinsIBA
01/2021
1lumbrokinaseIBA
12/2020
1integrin-linked kinaseIBA
11/2020
1Mechanistic Target of Rapamycin Complex 2IBA
11/2020
1Mechanistic Target of Rapamycin Complex 1IBA
11/2020
1propylene diquat (PDQ(+))IBA
11/2020
1Nitric Oxide Synthase (NO Synthase)IBA
11/2020
1Tuberculin (PPD)IBA
11/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020
1Neoplasm Antigens (Tumor Antigens)IBA
10/2020
1phenolic acidIBA
10/2020
1Histones (Histone)IBA
01/2020
1parthenolideIBA
01/2020
1MicellesIBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020

Therapy/Procedure

22Therapeutics
01/2022 - 07/2016
8Immunotherapy
01/2021 - 01/2018
4Corneal Transplantation (Keratoplasty)
01/2021 - 09/2013
3Drug Therapy (Chemotherapy)
10/2021 - 01/2020
2Penetrating Keratoplasty
01/2021 - 09/2013
1Chemoradiotherapy
10/2021
1Proton Therapy
10/2021
1Intravenous Administration
10/2020